Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Reexamination Certificate
2007-06-26
2007-06-26
Hartley, Michael G. (Department: 1618)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
C424S497000, C424S498000
Reexamination Certificate
active
10393549
ABSTRACT:
Pharmaceutical compositions of a particularly effective sparingly soluble glycogen phosphorylase inhibitor are disclosed, as well as methods of making such compositions and dosage forms from such compositions.
REFERENCES:
patent: 4950484 (1990-08-01), Olthoff et al.
patent: 4999200 (1991-03-01), Casillan
patent: 5085869 (1992-02-01), Olthoff et al.
patent: 5294298 (1994-03-01), Maesaka et al.
patent: 5464632 (1995-11-01), Cousin et al.
patent: 5490990 (1996-02-01), Grabowski et al.
patent: 5827541 (1998-10-01), Yarwood et al.
patent: 5837292 (1998-11-01), Dijkgraaf et al.
patent: 5924216 (1999-07-01), Takahashi
patent: 5955107 (1999-09-01), Augello et al.
patent: 5976577 (1999-11-01), Green et al.
patent: 5985326 (1999-11-01), Butler
patent: 6223455 (2001-05-01), Chickering, III et al.
patent: 6224909 (2001-05-01), Opitz et al.
patent: 6287596 (2001-09-01), Murakami et al.
patent: 6308434 (2001-10-01), Chickering, III et al.
patent: 6316029 (2001-11-01), Jain et al.
patent: 2001/0027614 (2001-10-01), Chickering, III et al.
patent: 2002/0003146 (2002-01-01), Long
patent: 2002/0031547 (2002-03-01), Takagi et al.
patent: 0 784 974 (1997-07-01), None
patent: 0846464 (1998-06-01), None
patent: 0 901 786 (1999-03-01), None
patent: 0901786 (1999-03-01), None
patent: 1027886 (2000-08-01), None
patent: 1027887 (2000-08-01), None
patent: 1027888 (2000-08-01), None
patent: 2000 072676 (2000-03-01), None
patent: WO 0147495 (2001-07-01), None
patent: WO 0147500 (2001-07-01), None
Touitou, E. et al., International Journal of Pharmaceutics, vol. 11, pp. 131-148, 1982, Influence of Additives on (Hydroxyethyl) Methylcellulose Properties: Relation Between Gelation Temperature Change, Compressed Matrix Integrity and Drug Release Profile.
Catellani, P. L. et al., International Journal of Pahrmaceutics, vol. 51, pp. 63-66, 1989, “Tablet Water Uptake and Disintegration Force Measurements”.
Colombo, P. et al., vol. 73, No. 5, pp. 701-705, May 1984, “Disintegrating Force as a New Formulation Parameter”.
Massimo, G. et al., vol. 5(2), pp. 163-169, 2000, “Disintegration Propensity of Tablets Evaluated by Means of Disintegrating Force Kinetics”.
Sinko, C. M. et al., International Journal of Pharmaceutics, vol. 114, pp. 85-93, 1995, “The Identification of Percolation and Mechanical Thresholds During the Compaction of Hydroxypropyl Methylcellulose: Comparison to Thresholds Determined from Out-of-Die Indentation Experiments”.
Berman, J. et al., Drug Development and Industrial Pharmacy, vol. 20(5), pp. 731-755 (1994), “Scale-Up of a Spray Dry Tablet Granulation Process: Thermodynamic Considerations”.
Yu, L., Advanced Drug Delivery Reviews, vol. 48, pp. 27-42, 2000, “Amorphous Pharmaceutical Solids: Preparation, Characterization and Stabilization”.
Christensen, K. L. et al., International Journal of Pharmaceutics, vol. 212, pp. 195-202, 2001, “Technical Optimisation of Redispersible Dry Emulsions”.
Yoo, S. D. et al., Drug Development and Industrial Pharmacy, vol. 26(1), pp. 27-34, 2000, “Bioavailability of Itraconazole in Rats and Rabbits After Administration of Tablets Containing Solid Dispersion Particles”.
H. Bauer, M. Bartels, E. Schwarz, and P.C. Schmidt, Particle Design by Surface Modifications: Spray-Drying and Co-Granulation of Mannitol/Sorbitol Mixtures,S.T.P. Pharma Sci., 2001, vol. 11, No. 3, pp. 203-209.
Pharmaceutics: The Science of Dosage Form Design, pp. 156-158 (1988).
Crew Marshall D.
Friesen Dwayne T.
Hancock Bruno C.
Macri Chris
Nightingale James A. S.
Benson Gregg C.
Fubara Blessing
Hartley Michael G.
Jones James T.
Pfizer Inc
LandOfFree
Pharmaceutical compositions of a sparingly soluble glycogen... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions of a sparingly soluble glycogen..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions of a sparingly soluble glycogen... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3836683